Review



alphalisa readings  (BMG Labtech)


Bioz Verified Symbol BMG Labtech is a verified supplier
Bioz Manufacturer Symbol BMG Labtech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    BMG Labtech alphalisa readings
    G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by <t>AlphaLISA</t> in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.
    Alphalisa Readings, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 99/100, based on 3904 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alphalisa+readings/pmc12445851-62-0-8?v=BMG+Labtech
    Average 99 stars, based on 3904 article reviews
    alphalisa readings - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "G protein-coupled receptor 35 stimulation reduces osteoclast activity in primary human bone cells"

    Article Title: G protein-coupled receptor 35 stimulation reduces osteoclast activity in primary human bone cells

    Journal: JBMR Plus

    doi: 10.1093/jbmrpl/ziaf131

    G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by AlphaLISA in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.
    Figure Legend Snippet: G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by AlphaLISA in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Techniques Used: Activation Assay, Protein-Protein interactions, Phospho-proteomics, Transfection, Control

    G protein-coupled receptor 35 (GPR35) mediated effects on bone resorption and signaling are maintained in osteoclast-osteoblast co-cultures. (A) Quantification of toluidine blue-stained resorption pits and trenches formed on bone slices by osteoclast-osteoblast co-cultures exposed to vehicle, TC-G 1001, or TC-G 1001 and the ML145 antagonist (B) quantification of tartrate-resistant acid phosphatase enzyme activity in conditioned media from osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist. (C-F) quantification of (C) phosphorylated c-Src, (D) phosphorylated Akt1/2/3, (E) phosphorylated NFκB, (F) phosphorylated cAMP response element-binding protein in osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist, measured by AlphaLISA. Each point represents an independent donor. The gray line denotes mean. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test for A-B and with Dunnett’s multiple comparisons test for C-F. **** p < .0001, *** p < .001, ** p < .01, * p < .05.
    Figure Legend Snippet: G protein-coupled receptor 35 (GPR35) mediated effects on bone resorption and signaling are maintained in osteoclast-osteoblast co-cultures. (A) Quantification of toluidine blue-stained resorption pits and trenches formed on bone slices by osteoclast-osteoblast co-cultures exposed to vehicle, TC-G 1001, or TC-G 1001 and the ML145 antagonist (B) quantification of tartrate-resistant acid phosphatase enzyme activity in conditioned media from osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist. (C-F) quantification of (C) phosphorylated c-Src, (D) phosphorylated Akt1/2/3, (E) phosphorylated NFκB, (F) phosphorylated cAMP response element-binding protein in osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist, measured by AlphaLISA. Each point represents an independent donor. The gray line denotes mean. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test for A-B and with Dunnett’s multiple comparisons test for C-F. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Techniques Used: Staining, Activity Assay, Binding Assay



    Similar Products

    alphalisa readings  (BMG Labtech)
    99
    BMG Labtech alphalisa readings
    G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by <t>AlphaLISA</t> in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.
    Alphalisa Readings, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alphalisa+readings/pmc12445851-62-0-8?v=BMG+Labtech
    Average 99 stars, based on 1 article reviews
    alphalisa readings - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by AlphaLISA in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Journal: JBMR Plus

    Article Title: G protein-coupled receptor 35 stimulation reduces osteoclast activity in primary human bone cells

    doi: 10.1093/jbmrpl/ziaf131

    Figure Lengend Snippet: G protein-coupled receptor 35 (GPR35) activation reduces c-Src and PI3K-Akt signaling pathways in mature osteoclasts. Quantification of phosphorylated (A) c-Src (pSrc), (B) Akt1/2/3 (pAkt), and (C) p38 (p-p38) measured by AlphaLISA in osteoclasts exposed to vehicle or GPR35 agonists with or without GPR35 antagonist ML145. (D-E) Quantification of (D) c-Src and (E) Akt1/2/3 phosphorylation in mature osteoclasts transfected with scrambled or GPR35 siRNA exposed to vehicle or GPR35 agonist, TC-G 1001. Data in all panels was normalized to GAPDH as a housekeeper control. Each point represents an independent donor in all panels. The gray line denotes mean in panels a, B, D and E and median in panel C. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test in panels A, B, D, and E and Kruskal–Wallis with Dunn’s multiple comparisons test in C. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Article Snippet: AlphaLISA readings were made on a PHERAstar FS (BMG Labtech, Aylesbury, United Kingdom) plate reader, and values for phosphorylated proteins normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) values.

    Techniques: Activation Assay, Protein-Protein interactions, Phospho-proteomics, Transfection, Control

    G protein-coupled receptor 35 (GPR35) mediated effects on bone resorption and signaling are maintained in osteoclast-osteoblast co-cultures. (A) Quantification of toluidine blue-stained resorption pits and trenches formed on bone slices by osteoclast-osteoblast co-cultures exposed to vehicle, TC-G 1001, or TC-G 1001 and the ML145 antagonist (B) quantification of tartrate-resistant acid phosphatase enzyme activity in conditioned media from osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist. (C-F) quantification of (C) phosphorylated c-Src, (D) phosphorylated Akt1/2/3, (E) phosphorylated NFκB, (F) phosphorylated cAMP response element-binding protein in osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist, measured by AlphaLISA. Each point represents an independent donor. The gray line denotes mean. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test for A-B and with Dunnett’s multiple comparisons test for C-F. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Journal: JBMR Plus

    Article Title: G protein-coupled receptor 35 stimulation reduces osteoclast activity in primary human bone cells

    doi: 10.1093/jbmrpl/ziaf131

    Figure Lengend Snippet: G protein-coupled receptor 35 (GPR35) mediated effects on bone resorption and signaling are maintained in osteoclast-osteoblast co-cultures. (A) Quantification of toluidine blue-stained resorption pits and trenches formed on bone slices by osteoclast-osteoblast co-cultures exposed to vehicle, TC-G 1001, or TC-G 1001 and the ML145 antagonist (B) quantification of tartrate-resistant acid phosphatase enzyme activity in conditioned media from osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist. (C-F) quantification of (C) phosphorylated c-Src, (D) phosphorylated Akt1/2/3, (E) phosphorylated NFκB, (F) phosphorylated cAMP response element-binding protein in osteoclast-osteoblast co-cultures exposed to GPR35 agonists or agonists with antagonist, measured by AlphaLISA. Each point represents an independent donor. The gray line denotes mean. Statistical analyses were performed by one-way ANOVA with Holm-Šídák’s multiple comparisons test for A-B and with Dunnett’s multiple comparisons test for C-F. **** p < .0001, *** p < .001, ** p < .01, * p < .05.

    Article Snippet: AlphaLISA readings were made on a PHERAstar FS (BMG Labtech, Aylesbury, United Kingdom) plate reader, and values for phosphorylated proteins normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) values.

    Techniques: Staining, Activity Assay, Binding Assay